Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Initial rFSH dosing in GnRH antagonist COH for insulin-resistant PCOS
ChiCTR2400091719Phase 4Not yet recruiting
- Sponsor
- Guangdong Provincial People's Hospital
- Start
- Nov 2024
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised trial of follitropin alfa in polycystic ovary syndrome (PCOS), insulin resistance (IR) and female infertility (3 arms), sponsored by Guangdong Provincial People's Hospital. Primary endpoint: Clinical pregnancy rate for first embryo transfer cycle. Planned start Nov 2024; status: not yet recruiting.
02
Drugs
follitropin alfa
03
Conditions
polycystic ovary syndrome (PCOS)insulin resistance (IR)female infertility
Beyond the preview
Go deeper on ChiCTR2400091719.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400091719.